Neurohormonal Activation and the Chronic Heart Failure Syndrome in Adults With Congenital Heart Disease
Author(s) -
Aidan P. Bolger,
Rakesh Sharma,
Wei Li,
Marjolein F. E. Leenarts,
Paul R. Kalra,
Michael Kemp,
Andrew J.S. Coats,
Stefan D. Anker,
Michael Α. Gatzoulis
Publication year - 2002
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/01.cir.0000020009.30736.3f
Subject(s) - medicine , heart failure , heart disease , atrial natriuretic peptide , asymptomatic , aldosterone , endocrinology , natriuretic peptide , brain natriuretic peptide , cardiology , norepinephrine , plasma renin activity , renin–angiotensin system , blood pressure , dopamine
Neurohormonal activation characterizes chronic heart failure, relates to outcome, and is a therapeutic target. It is not known whether a similar pattern of neurohormonal activation exists in adults with congenital heart disease and, if so, whether it relates to common measures of disease severity or whether cardiac anatomy is a better discriminant.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom